Search & Filter
News Type
Topic
Disease
Population
NFID Statement on COVID-19 Vaccine Safety
FOR IMMEDIATE RELEASE Bethesda, MD (April 13, 2021)—The following statement can be attributed to William Schaffner, MD, medical director of the National Foundation for Infectious…
What Have We Learned from COVID-19?
During World Immunization Week, NFID will host the virtual 2021 Annual Conference on Vaccinology Research (ACVR) on April 26-27, 2021, with presentations from leaders in the field of vaccinology, including three keynote lectures on the implications of the COVID-19 pandemic. Read more about the changes and challenges these renowned experts have seen throughout their remarkable careers …
Effective Communications: The “Secret Sauce” for COVID-19 Vaccination
The COVID-19 pandemic has confronted health communicators with unprecedented challenges. To achieve widespread “vaccine literacy,” health communicators must apply basic educational principles to promote trustworthy, straightforward communication …
NFID Releases New Communications Framework to Promote COVID-19 Prevention Measures
Guidance Reflects Expertise from Leading Healthcare, Business, Union, and Education Groups Bethesda, MD (March 23, 2021)—The National Foundation for Infectious Diseases (NFID) issued a new…
ID News Round-Up: #COVID-19 Vaccination
A nationwide COVID-19 vaccination program is currently underway in the US. Where can you get vaccinated and when? What side effects can you expect? Will COVID-19 vaccines help end the pandemic? Read recent news of interest from the world of infectious diseases, with a focus on COVID-19 vaccination …
Recognizing #WomenInScience During Women’s History Month
Trailblazing women working in vaccinology will share stories about their individual paths and lessons learned throughout their careers at the 3rd Annual Women Leaders in Vaccinology Panel discussion during the 2021 Annual Conference on Vaccinology Research on April 26-27, 2021 …
Schaffner Report: New COVID-19 Vaccine and Other ACIP Updates
The Advisory Committee on Immunization Practices (ACIP) recently held two important meetings to review data on vaccines for influenza, hepatitis, pneumococcal disease, shingles, and other diseases, and to approve the new Janssen COVID-19 vaccine. Marla Dalton, executive director and CEO of the National Foundation for Infectious Diseases (NFID), talks with NFID Medical Director William Schaffner, MD, about the significance of these meetings for healthcare professionals and the public …
Black History Month: Vaccine Voices for COVID-19 Vaccine Choices
As we continue to tackle health equity issues, it is important to be open to embracing new partners and creating new champions. Although highlighting the contributions of Black scientists during Black History Month is important, addressing health equity can and should be done anytime and anywhere …